'Uncategorized' Category
By Simmons Hanly Conroy | March 30, 2015
Pharmaceutical News Wrap Up: March 2015
Interested in the latest pharmaceutical news? Simmons Hanly Conroy’s pharmaceutical attorneys understand the importance of staying up to date, which is why we’re providing the list of recent news stories below. Read… Read More
By Simmons Hanly Conroy | March 26, 2015
Pelvic Organ Prolapse Patients: Follow These Precautions For TVM Surgery
Pelvic organ prolapse (POP), caused by the weakening of the tissues that hold pelvic organs, may be experienced by 30-50 percent of women. Despite its controversial results, transvaginal surgical mesh is the… Read More
By Simmons Hanly Conroy | March 5, 2015
Testosterone Lawsuit News: FDA Orders Label Warnings on Testosterone Drugs
Testosterone therapy manufacturers must update the labels of all testosterone products to inform men about the increased risk of stroke, heart attack and death in patients taking testosterone, according to a testosterone… Read More
By Simmons Hanly Conroy | March 3, 2015
Xarelto and Internal Bleeding Frequently Asked Questions
Xarelto, an oral anticoagulant drug, is prescribed by doctors to reduce the risk of blood clots that may cause strokes. It is easier to use than many other blood thinners on the… Read More
By Simmons Hanly Conroy | February 27, 2015
Pharmaceutical News Wrap Up: February 2015
The pharmaceutical attorneys at Simmons Hanly Conroy know it’s essential to stay updated on the latest headlines, which is why we’re providing the list below. Read about recent U.S. Food and Drug… Read More
By Simmons Hanly Conroy | February 25, 2015
New Research Links Zofran to Increased Risk of Birth Defects in Pregnant Women
Morning sickness is a common side effect of pregnancy. According to the American Pregnancy Association, more than 50 percent of pregnant women experience some degree of morning sickness, vomiting or nausea. This… Read More
By Simmons Hanly Conroy | January 12, 2015
The Must-Know Facts about Blood-Thinning Medications
Blood thinning medications are used to prevent blood clots. Blood clots are health risks that increase chances of stroke, heart attack, and various other health issues. Warfarin is one of the original… Read More
By Simmons Hanly Conroy | December 31, 2014
Pharmaceutical News Wrap Up: December 2014
The pharmaceutical attorneys at Simmons Hanly Conroy understand the importance of staying up to date on the latest headlines. Below is a list of some of the most recent pharmaceutical news concerning… Read More
By Simmons Hanly Conroy | December 18, 2014
FDA Advisers Shown to Have Questionable Financial Ties
In July 2014, an adviser on a U.S. Food and Drug Administration (FDA) gynecology panel stepped down after he was questioned about conflicts of interest. It was later discovered that this panel… Read More
By Simmons Hanly Conroy | December 17, 2014
The History of Risperdal FDA Warnings
Risperdal was approved by the U.S. Food and Drug Administration (FDA) in 1994. It is recognized as a medication used to treat psychological issues. The antipsychotic drug is approved for use in patients… Read More
